NEOPHARMED GENTILI SPA is a security (CUSIP ZB0008761) tracked across SEC portfolio filings. 1 registered fund positions totaling $489K via N-PORT as of 2024-08-31.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. | BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. | $489K | 35.38% |